Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
04/01/20248:00AMGlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
03/20/20247:30AMGlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
02/27/20248:00AMGlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
02/14/20247:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/30/20248:00AMGlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
01/24/20248:00AMGlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
12/11/20231:00PMGlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
12/05/20237:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
12/01/20237:30AMGlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
11/27/20237:30AMGlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
11/08/20235:00PMGlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
10/12/20238:02AMGlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
06/16/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/30/20235:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/10/20234:35PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
04/28/20238:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
04/26/20234:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
04/25/20236:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
04/03/20235:29PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
04/03/20237:53AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/31/20239:19AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
02/08/20235:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/06/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
11/08/20224:45PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
09/12/20225:10PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS